Dr. Camilla Palumbo is an Assistant Professor of General Pathology (MED/04) at the Department of Clinical Sciences and Translational Medicine, University of Rome “Tor Vergata”. She graduated from the University "La Sapienza" with a Degree in Biological Sciences in 1995 and obtained her Ph.D. in Experimental Medicine at the University of L’Aquila in 2000. In 2004, she completed her specialization in Clinical Pathology at the University "La Sapienza". Among scientific articles, she has published 50 papers, totaling 9342 citations (h-index = 21, Scopus data from 18 January 2024).
Dr. Chiara Focaccetti is currently a Tenure track assistant professor RTD type B at the Department of Clinical Sciences and Translational Medicine, University of Rome “Tor Vergata”, Rome, Italy. Before that, she was a Researcher at the San Raffaele Telematic University of Rome from 2019 to 2021. She obtained her Ph.D. in Immunology at the Faculty of Medicine, University of Rome "Tor Vergata" with the thesis "Active immunotherapy inhibition of cancerogenesis process in breast tumor originated in ErbB2/neu transgenic mouse model” in 2007. She is a specialist in vivo scientist, cell biology scientist, and flow cytometry experience.
Patrizia Mancini received her Ph.D. from the Department of Experimental Medicine, Sapienza University of Rome in 1992. Then, she worked as a Post Doctorate Research Fellow at the Department of Cell Biology, Yale University, from 1992 to 1993. She served as a Researcher at the Department of Experimental Medicine from 1995 to 2005 and now has been working as an Associate Professor since 2005 at the Department of Experimental Medicine, Sapienza University of Rome.
Prof. Dr. Giovanni Barillari has been a Full Professor of Clinical Pathology at the Department of Clinical Sciences and Translational Medicine, Faculty of Medicine and Surgery, University of Rome "Tor Vergata" since 2006. From 2000 to 2006, he was an Associate Professor of General Pathology at the Faculty of Medicine and Surgery, University of the Studies of Rome "Tor Vergata", and at the same university, he served as a Researcher at the Department of Experimental Medicine from 1993 to 2000. He graduated from the University of Rome "Sapienza" with a Degree in Medicine and Surgery in 1983, where he completed his specialization in General Pathology in 1987. In 1990, he completed his Master's Course in DNA Research Methods, at FAES, USA. Moreover, he is a reviewer of scientific research projects presented to the Ministry of Health or the Ministry of University and Research. In this context, he is registered in the register of independent experts, Italian and foreign (Register of Expert Peer Reviewers for Italian Scientific Evaluation, REPRISE), established at the Ministry of University and Research.
Prof. Dr. Loredana Cifaldi is an Associate Professor of General Pathology at the Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy, where she was an Assistant Professor (RTDb-tenure track) from July 2020 to July 2023. in addition, she is a Research Fellow at the Academic Department of Pediatrics, Research Unit of Congenital and Perinatal Infection, Ospedale Pediatrico Bambino Gesu. She graduated from the University of Camerino with a Degree in Biology in 1997. In 2017, she completed studies at the School of Specialization in Clinical Biochemistry, at the University of Turin. Among scientific articles, she has published 50 papers, totaling 2080 citations (h-index = 23, Scopus data from 18 January 2024).
Prof. Dr. Laura Masuelli is an Associate professor at the Department of Experimental Medicine, School of Medicine, University of Rome “Sapienza”, Rome, Italy. She obtained her M.D. Degree in Medicine at the University of Rome "Sapienza" in 1989. Then, in 1995, she completed Ph.D. studies. From 1992 to 1996, she served as a Postdoctoral fellow at the NIH, NCI, LTIB, Bethesda MD, USA. Her research fields are cancer immunotherapy, cell signaling in tumor cells, ultrastructural analysis of viral particles and nanoparticles, and ultrastructural diagnosis of human disease.
Dr. Monica Benvenuto is a Researcher at the “Saint Camillus International University of Health and Medical Sciences” of Rome. She graduated in Medical Biotechnology at the University of Rome “Tor Vergata” and received a Ph.D. in Molecular Medicine at the University of Rome “Sapienza”. She was a research fellow at the University of Rome “Tor Vergata” for several years. Her research activity is focused on the development of new experimental approaches for the treatment of tumors: cancer immunotherapy and the study of the in vitro and in vivo effects of natural compounds, anticancer vaccines, and intracellular signaling transduction pathways inhibitors on cancer cell growth. She is the author of several publications in international journals of high scientific quality.
Prof. Dr. Roberto Bei, MD, PhD is a Full Professor of General Pathology at the University of Rome “Tor Vergata” (Italy). He obtained his Degree in Medicine and his PhD at the University of Rome “Sapienza” in 1989 and 1998, respectively. He is a Specialist in Medical Oncology and Clinical Pathology. He joined, as a post-doctoral fellow (1992–1996), the LTIB and NIH (Director: DR. J. Schlom), where he started to work in the field of cancer immunotherapy. The teaching activity of Prof. Bei includes lectures on General Pathology in the School of Medicine, Medical Biotechnology, Pharmacy, Dietician, Residency in Endocrinology, and Oncology. His research is focused on cancer immunotherapy and the effects of natural compounds on cancer cell growth. He is a member of the editorial board of several journals.
